cytosine has been researched along with Anogenital Type Verrucous Carcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nambudiri, VE | 1 |
| Mutyambizi, K | 1 |
| Walls, AC | 1 |
| Fisher, DC | 1 |
| Bleday, R | 1 |
| Saavedra, AP | 1 |
| Gormley, RH | 1 |
| Kovarik, CL | 1 |
1 review available for cytosine and Anogenital Type Verrucous Carcinoma
| Article | Year |
|---|---|
Human papillomavirus-related genital disease in the immunocompromised host: Part II.
Topics: Adjuvants, Immunologic; Alphapapillomavirus; Aminoquinolines; Antineoplastic Agents, Phytogenic; Ant | 2012 |
1 other study available for cytosine and Anogenital Type Verrucous Carcinoma
| Article | Year |
|---|---|
Successful treatment of perianal giant condyloma acuminatum in an immunocompromised host with systemic interleukin 2 and topical cidofovir.
Topics: Administration, Topical; Antineoplastic Agents; Antiviral Agents; Anus Neoplasms; Buschke-Lowenstein | 2013 |